Kexing Biopharm Co., Ltd. Class A news

Investor announcements, newest first.

Close
Company news
Kexing Biopharm Co., Ltd. Class A
May 14, 2026
May 14
May 14, 2026
Original

Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of GB10 for Injection

Announcement on Voluntary Disclosure of Completion of Inclusion of the First Subject in Phase 1 Clinical Trial of GB10 for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment